NEW YORK, July 8 - Expression Pathology, a Rockville, Md., protein array startup, said late yesterday it had been awarded an $100,000 Phase I Small Business Innovation Research grant from the NCI.
The company plans to use the grant to further develop its technology for arraying proteins. Expression pathology used laser tissue microdissection technology to collect proteins from formalin-fixed tissue, then converts the protein-containing into a liquid format for high-throughput arraying.
The company incorporates this technology into a HistoChip molecular profiling system, which links data on tissue proteins directly to histopathology information.